The paradigm of prophylactic viral outbreaks measures by microbial biosurfactants. Issue 4 (April 2023)

• Record Type: Journal Article
• Authors: Kumari, Khushbu; Nandi, Aditya; Sinha, Adrija; Ghosh, Aishee; Sengupta, Srabasti; Saha, Utsa; Singh, Pawan K.; Panda, Pritam Kumar; Raina, Vishakha; Verma, Suresh K.
• Is Part Of: Journal of infection and public health. Volume 16:Issue 4(2023)
• Page Start: 575
• Page End: 587
• Publication Date: 2023-04
• Subjects: COVID-19 -- Biosurfactants -- Antioxidant -- Antiviral; Communicable diseases -- Periodicals; Public health -- Periodicals; Epidemiology -- Periodicals; Nosocomial infections -- Prevention -- Periodicals; Medical microbiology -- Periodicals; 614.4
• DOI: 10.1016/j.jiph.2023.02.016
• Languages: English
• ISSNs: 1876-0341

Abstract

Abstract: The recent emergence and outbreak of the COVID-19 pandemic confirmed the incompetence of countries across the world to deal with a global public health emergency. Although the recent advent of vaccines is an important prophylactic measure, effective clinical therapy for SARS-Cov-2 is yet to be discovered. With the increasing mortality rate, research has been focused on understanding the pathogenic mechanism and clinical parameters to comprehend COVID-19 infection and propose new avenues for naturally occurring molecules with novel therapeutic properties to alleviate the current situation. In accordance with recent clinical studies and SARS-CoV-2 infection markers, cytokine storm and oxidative stress are entwined pathogenic processes in COVID-19 progression. Lately, Biosurfactants (BSs) have been studied as one of the most advanced biomolecules of microbial origin with anti-inflammatory, antioxidant, antiviral properties, antiadhesive, and antimicrobial properties. Therefore, this review inspects available literature and proposes biosurfactants with these properties to be encouraged for their extensive study in dealing with the current pandemic as new pharmaceutics in the prevention and control of viral spread, treating the symptoms developed after the incubation period through different therapeutic approaches and playing a potential drug delivery model.